Hanmi Pharmaceutical, founded in 1973 by pharmacist Lim Sung-ki, is a leading R&D driven biopharmaceutical company in Korea. Guided by the principles of “Respect for Humanity” and “Value Creation,” Hanmi is committed to advancing innovation based on its founder’s conviction to develop better medicines through proprietary technology.
Early bird registration is open and closes 23 June 2026. Register now
d
h
m
s
Abstracts deadline Friday 24 April 2026! Submit now
d
h
m
s
Abstracts deadline EXTENDED Friday 22 May 2026! Submit now
d
h
m
s
